National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study ...Middle East

MORRISVILLE, N.C., Nov. 23, 2020 /PRNewswire/ -- Metabolon, Inc. will participate in the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Immunophenotyping Assessment in a COVID-19 Cohort, or IMPACC, study (grant no:...

Hence then, the article about national institute of allergy and infectious disease niaid selects metabolon inc for covid 19 study was published today ( Monday 23/11/2020 - 06:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study )

Also on site :

• MAGA Influencer Scott Presler Denied Entry To GOP Event, Blames Thune
• 3 New Netflix Shows You Need to Binge This Weekend (June 26-28, 2026)
• Quote of the Day: Yogi Berra on Why 'A Nickel Ain't Worth a Dime' Anymore